查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1476497

藥物發現外包的市場規模 - 按工作流程、治療領域、藥物類型和最終用戶分類 - 區域前景、競爭策略和細分市場預測（截至 2033 年）

Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到2033年，全球藥物發現外包市場規模將成長至85.9億美元，複合年成長率為7.71%。

藥物發現外包是藥理學、生技和製藥等各領域發現新藥和治療方法的方式之一。這種方法的成功率相對較低，並且是一個勞動密集過程。然而，在該行業中，大大小小的參與者開發新藥並將其提供給較大的參與者進行臨床後測試，以檢驗和保證藥物的有效性。

COVID-19 對藥物發現行業產生了重大影響。這是由於過去三年製藥和生物技術公司對疫苗的高需求。為了創造強大的抗病毒藥物，在藥物研究中藉用外部幫助變得至關重要。隨著生物技術和製藥行業的公司將研究委託給 CRO，COVID-19 對市場成長產生了重大影響。這些業務包括使用體外和體內模型的基礎研究以及早期臨床開發。

該報告調查了全球藥物發現外包市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素、抑制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭狀況

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章 全球藥物發現外包市場：依工作流程

  • 全球市佔率及預測
  • 目標驗證/功能資訊學
  • 潛在客戶識別/候選最佳化
  • 臨床前開發
  • 目標識別/篩檢
  • 其他

第8章 全球藥物發現外包市場：依治療領域

  • 全球市佔率及預測
  • 心血管
  • 中樞神經系統
  • 胃
  • 血
  • 呼吸系統
  • 感染疾病
  • 瘤
  • 免疫
  • 其他

第9章全球藥物發現外包市場：依藥物類型

  • 全球市佔率及預測
  • 低分子
  • 高分子

第10章全球藥物發現外包市場：依最終用戶分類

  • 市場規模/市場佔有率趨勢/預測
  • 製藥和生物技術公司
  • 學術機構
  • 其他

第11章 全球藥物發現外包市場預測

  • 市場規模/市場佔有率趨勢/預測

第12章全球藥物發現外包市場：按地區

  • 市場規模/市場佔有率趨勢/預測
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第13章 公司簡介

  • Charles River Laboratories
  • Curia Global Inc.
  • Dalton Pharma Service
  • Dr. Reddy's Laboratories
  • Discover X Corporation
  • Laboratory Corporation of America
  • Merck & Co
  • Syngene International Ltd.
  • TCG Life Science Pvt. Ltd.
  • Thermo Fisher Scientific, Inc.
  • 其他

第14章簡稱

第15章 參考鏈接

第16章結論

第17章 研究範圍

簡介目錄
Product Code: HLCA2436

Drug Discovery Outsourcing Market Introduction and Overview

According to SPER market research, Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Drug Discovery Outsourcing Market is predicted to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.

One way to uncover new medications or therapeutics in a variety of sectors, including pharmacology, biotechnology, and pharmaceuticals, is through drug discovery outsourcing. This approach has a relatively poor success rate in drug development and is a labor-intensive procedure. Nonetheless, both large and tiny producers in the industry create novel medications and provide them to well-known competitors for examination after clinical trials to determine and guarantee the medications' efficacy.

Because several pharmaceutical and biotech businesses have been in high demand for vaccine discovery over the last three years, COVID-19 has had a substantial influence on the drug discovery industry. Using outside help for drug research has become essential to creating potent anti-virus therapies. Because businesses in the biotech and pharmaceutical sectors were progressively outsourcing research efforts to CROs, COVID-19 had a major effect on the market's growth. These operations comprised basic research employing in vitro and in vivo models as well as early-stage clinical development.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Workflow, By Therapeutic Area, By Drug Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy's Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd.

Drug Discovery Outsourcing Market Segmentation

By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.

By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others

By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market

7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033

  • 7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-2026
  • 7.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-2033
  • 7.3. Target Validation and Functional Informatics
  • 7.4. Lead Identification and Candidate Optimization
  • 7.5. Preclinical Development
  • 7.6. Target Identification and Screening
  • 7.7. Others

8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033

  • 8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)
  • 8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)
  • 8.3. Cardiovascular
  • 8.4. Central Nervous System
  • 8.5. Gastrointestinal
  • 8.6. Haematology
  • 8.7. Respiratory System
  • 8.8. Infectious Disease
  • 8.9. Oncology
  • 8.10. Immunology
  • 8.11. Others

9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033

  • 9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)
  • 9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)
  • 9.3. Small Molecules
  • 9.4. Large Molecules

10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033

  • 10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)
  • 10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)
  • 10.3. Pharmaceutical and Biotechnological Companies
  • 10.4. Academia Institutions
  • 10.5. Others

11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Drug Discovery Outsourcing Market Size and Market Share

12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)

  • 12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)
  • 12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)
  • 12.3. Asia-Pacific
    • 12.3.1. Australia
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. Japan
    • 12.3.5. South Korea
    • 12.3.6. Rest of Asia-Pacific
  • 12.4. Europe
    • 12.4.1. France
    • 12.4.2. Germany
    • 12.4.3. Italy
    • 12.4.4. Spain
    • 12.4.5. United Kingdom
    • 12.4.6. Rest of Europe
  • 12.5. Middle East and Africa
    • 12.5.1. Kingdom of Saudi Arabia
    • 12.5.2. United Arab Emirates
    • 12.5.3. Qatar
    • 12.5.4. South Africa
    • 12.5.5. Egypt
    • 12.5.6. Morocco
    • 12.5.7. Nigeria
    • 12.5.8. Rest of Middle-East and Africa
  • 12.6. North America
    • 12.6.1. Canada
    • 12.6.2. Mexico
    • 12.6.3. United States
  • 12.7. Latin America
    • 12.7.1. Argentina
    • 12.7.2. Brazil
    • 12.7.3. Rest of Latin America

13. Company Profile

  • 13.1. Charles River Laboratories
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Curia Global Inc.
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Dalton Pharma Service
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Dr. Reddy's Laboratories
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Discover X Corporation
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. Laboratory Corporation of America
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Merck & Co
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Syngene International Ltd.
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. TCG Life Science Pvt. Ltd.
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Thermo Fisher Scientific, Inc.
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope